DC Chemicals

All products / DC8828

HDAC inhibitor IV
CAT. NO. DC8828

HDAC inhibitor IV

Pack sizes and prices

Pack sizePrice
100 mg$450 USDRequest a quote / confirm availability →
250 mg$800 USDRequest a quote / confirm availability →
1 g$1,600 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

HDAC inhibitor IV is a cell-permeable pimeloylanilide compound that acts as a FXN- (frataxin gene) specific HDAC (histone deacetylase) inhibitor. Reverses the silencing of FXN transcription in FRDA (Friedreich's ataxia) cells (~3-fold increase of FXN mRNA at 5 µM in primary FRDA lymphocytes and ~3-fold frataxin expression in FRDA cell line at 2.5 µM) due to hypoacetylation of histones H3 and H4 by increasing acetylation at H3K14, H4K5 and H4K12, without significant changes in acetylation at H3K9, H4K8 and H4K16. In comparison, Trichostatin-A and SAHA, two other commonly used HDAC inhibitors, exhibit no effect on FXN transcription.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC8828
Product nameHDAC inhibitor IV
CAS537034-15-4
Molecular formulaC19H23N3O2
Molecular weight325.40500
Purity>98%
SMILESNc1ccccc1NC(=O)CCCCCC(=O)Nc1ccccc1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — HDAC inhibitor IV (DC8828)

Related research products

Browse newly added products